Niagen Bioscience Stock (NASDAQ:NAGE)
Previous Close
$3.47
52W Range
$3.35 - $14.69
50D Avg
$4.22
200D Avg
$6.14
Market Cap
$273.18M
Avg Vol (3M)
$936.29K
Beta
2.06
Div Yield
-
NAGE Company Profile
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
NAGE Performance
Peer Comparison
| Ticker | Company |
|---|---|
| KALV | KalVista Pharmaceuticals, Inc. |
| RGNX | REGENXBIO Inc. |
| RIGL | Rigel Pharmaceuticals, Inc. |
| PRTA | Prothena Corporation plc |
| AKBA | Akebia Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| KROS | Keros Therapeutics, Inc. |
| OLMA | Olema Pharmaceuticals, Inc. |
| CRVS | Corvus Pharmaceuticals, Inc. |
| ZVRA | Zevra Therapeutics, Inc. |